Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00515060 · ClinicalTrials.gov registry record

Psychophysical Studies of Cancer Therapy Pain

A clinical trial of Pain and Advanced Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
450
Enrollment target
1
Study location

NCT00515060 is a study of Pain and Advanced Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 450 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (49% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00515060, a study of Pain and Advanced Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
450 participants
Enrollment target
1
Study location

Study Summary

The Aim of this Study is to examine the feasibility of using quantitative sensory testing procedures, widely applied to the experimental study of sensory processing in humans both with and without various pain syndromes, to now characterize the psychophysical properties of neuropathic pain that has developed as a consequence of cancer therapy. Skin punch biopsies will be performed in patients with chemotherapy-induced pain to determine whether the impairment of nerve function is due to actual retraction or loss of innervation to the skin in areas affected by sensory disturbance.

Conditions Studied

Interventions

  • OTHER Sensory Tests

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2001-01-23
Est. Completion 2028-04-30

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00515060

The ClinicalTrials.gov registry entry for NCT00515060 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 303-participant average among 374 other Pain trials with a reported enrollment target (49% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Sensory Tests is the first listed.

NCT00515060 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00515060 about?

NCT00515060 is a clinical study titled "Psychophysical Studies of Cancer Therapy Pain". The Aim of this Study is to examine the feasibility of using quantitative sensory testing procedures, widely applied to the experimental study of sensory processing in humans both with and without various pain syndromes, to now characterize the psychophysical properties of neuropathic pain that has ...

What is the current status of trial NCT00515060?

This trial is currently recruiting. The enrollment target is 450 participants. The study started on 2001-01-23. Estimated completion is 2028-04-30.

What conditions does trial NCT00515060 study?

This clinical trial studies the following conditions: Pain, Advanced Cancer.

What interventions are being tested in trial NCT00515060?

The interventions under investigation include: Sensory Tests (OTHER).

Who is sponsoring clinical trial NCT00515060?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00515060 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.